Guyana to introduce 9-valent HPV vaccine in cervical cancer fight

Guyana will transition from the quadrivalent to the 9-valent Human Papillomavirus (HPV) vaccine as part of its national strategy to eliminate cervical cancer.

The announcement was made by Health Minister Dr Frank Anthony during a recent Cardiology Symposium at the Arthur Chung Conference Centre.

The 9-valent vaccine provides broader protection against HPV strains compared to its predecessor and is expected to strengthen the country’s preventive efforts, said Dr Anthony.

Health authorities aim to build on existing high coverage rates, with national vaccination levels reported at nearly 90 per cent.

The initiative forms part of a wider cancer prevention and treatment agenda. In addition to the HPV vaccine upgrade, the government has launched a programme focused on prostate cancer, offering Prostate-Specific Antigen (PSA) testing and biopsies to support early diagnosis and timely intervention.

The ministry also plans to enhance oncology services through the development of a specialised cancer care facility at the upcoming maternal and paediatric hospital. The centre, a collaboration with the Mount Sinai Health System, will provide advanced diagnostic and treatment options for cancer patients.